Gamma-aminobutyric acid (GABA) is a non-proteinogenic amino acid act as a major neurotransmitter inhibitor in the nervous system of mammals. It also used as a precursor of bioplastics synthesis such as N-methylpyrolidone and polyamide 4. Chemical-based synthesis methods have many environmental-related issues, so efforts have been made to develop biosynthetic methods to produce GABA. Glutamate decarboxylase (GAD) transforms L-glutamate to GABA using pyridoxal 5′-phosphate (PLP) as a cofactor. Bioconversion of GABA with whole cells overexpressing the glutamate decarboxylase has advantages of fewer byproducts and rapid reaction. However, there is a bottleneck in the whole-cell bioconversion system i.e., higher GABA production require a large amount of cofactor PLP which make the process costly. Therefore, pyridoxal kinase (PdxY) able to regenerate PLP was introduced in the whole-cell system to construct a new GABA producing system. Culture and reaction conditions were optimized, and 100% conversion of 0.6 M MSG was obtained. This study reports that a competitive level of GABA production could be achieved without supplying additional PLPs.
This study was supported by Research Program to solve social issues of the National Research Foundation of Korea (NRF)s funded by the Ministry of Science and ICT [Grant no. 2017M3A9E4077234] and National Research Foundation of Korea (NRF) [NRF-2019M3E6A1103979 and NRF-2021R1F1A1050325]. This study was also performed with the support of the Research and Development Program of MOTIE/KEIT [Grant no. 20014350 and 20016324]. This research was supported by \u201cCooperative Research Program for Agriculture Science & Technology Development (Project no. PJ0154982021), Rural Development Administration, Republic of Korea.